Medicine & Health

People prescribed the popular GLP-1 weight-loss drugs such as Ozempic and Mounjaro may experience benefits such as increased cognitive and behavioral health, according to scientists at WashU Medicine and the Veterans Affairs St. Louis Health Care System. But users may also face increased risks for pancreatitis and kidney conditions, among other illnesses.

Researchers at WashU Medicine have described the neurodegeneration that occurs in the nervous system of the bowel in Batten disease, a rare and fatal genetic condition.

Researchers at the McKelvey School of Engineering have turned an age-old assumption about cell force on its head. Their work, published in PLOS Computational Biology, has implications for how cancer spreads and wounds heal.

The Internal Medicine Residency Program at WashU Medicine has received the Accreditation Council for Graduate Medical Education 2025 Barbara Ross-Lee, DO Diversity, Equity, and Inclusion Award.

Mice infected with the bacteria that cause tuberculosis (TB) fared better when treated with an experimental compound that modulates immune responses, according to a study led by Christina Stallings, a professor of molecular microbiology at WashU Medicine.

WashU Medicine researchers have been awarded nearly $5 million to better understand what causes pain symptoms to persist in some patients recovering from surgery.

Kory Lavine, MD, PhD, the Alan A. and Edith L. Wolff Professor of Cardiology at WashU Medicine, has received a $600,000 grant from the Additional Ventures Foundation — an organization that funds research into congenital heart disease — to study hypoplastic left heart syndrome.

Gregory Lanza, MD, PhD, the James R. Hornsby Family Professor in Biomedical Sciences at WashU Medicine, has been named a fellow of the National Academy of Inventors in recognition of his application of nanotechnology to a broad variety of medical innovations.

WashU Medicine secured $683 million in research funding from the National Institutes of Health (NIH) in 2024, placing the school at No. 2 in NIH funding nationwide for the second year in a row.

Burel R. Goodin, a professor of anesthesiology at WashU Medicine, has received more than $3 million from the National Institutes of Health (NIH) to support postdoctoral training.